Treatment of Advanced Gastrointestinal Tumors With Albumin Taxol

Advanced Gastrointestinal Tumors Clinical Trial

Official title:
A Retrospective Clinical Study on the Efficacy and Safety of Injection Taxol (Albumin Binding Type) in the Treatment of Patients With Advanced Gastrointestinal Tumors

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study was to evaluate the safety and efficacy of domestic injection paclitaxel (albumin binding type) in patients with advanced digestive tract tumors,and to further explore the possible predictors of efficacy.In order to provide more effective chemotherapeutic drugs, prolong survival time and improve quality of life for patients with advanced digestive tract tumors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03977077
Study type	Interventional
Source	Henan Cancer Hospital
Contact	Xifang Hou
Phone	15136130286
Email	houxinfang2013@163.com
Status	Not yet recruiting
Phase	N/A
Start date	June 1, 2019
Completion date	October 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01916447` - A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.	Phase 1
Recruiting	`NCT06197178` - A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)	Phase 1
Recruiting	`NCT04612712` - A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors	Phase 1/Phase 2
Completed	`NCT01927965` - Study of Minnelide™ in Patients With Advanced GI Tumors	Phase 1